NCT05382104 - Maribavir Food-Effect Study in Healthy Adults Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 25, 2022

Primary Completion Date

July 2, 2022

Study Completion Date

July 2, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

Maribavir

Maribavir single 400 mg tablet under three different food conditions (fasted, low fat/low calorie meal, and high fat/high calorie meal) depending upon the treatment sequence allocation on Day 1 of each treatment period.

Trial Locations (1)

68502

Celerion, Lincoln